A minority of tumours were screen-detected (17, 6.6%), most were invasive ductal carcinoma (189, 73.3%), most commonly ER positive (161, 62.4%), and over half were PR positive (141, 54.7%). The gene discussed is PGR; the disease is invasive ductal breast carcinoma.